Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/25/2022 | Press release | Distributed by Public on 01/25/2022 10:41
Please select the service you want to use:
Smartlinks | eXp World Holdings Inc. | News | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Company Appointments | Corporate Officer Change | Financial Services | Investment Services | Real Estate | Media and Publishing | Newspaper and Magazines | News Media | Public Companies | Real Estate Development and Management Companies | Bolsa Mexicana de Valores (BMV) | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact